HUMAN GENOME SCIENCES INC Investing Cash Flow
HUMAN GENOME SCIENCES INC reported Investing Cash Flow of $71.62 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC net cash provided by (used in) investing activities for the quarter ending 2012-06-30 was $42.17M, a 56.11% decline year-over-year.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) investing activities for the quarter ending 2012-03-31 was $29.45M, a 19.84% increase year-over-year.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) investing activities for the quarter ending 2011-12-31 was $95.49M, a 6387.23% increase year-over-year.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) investing activities for the quarter ending 2011-09-30 was $61.20M, a 7116.51% increase year-over-year.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) investing activities for fiscal 2011 was $277.34M.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) investing activities for fiscal 2010 was -$167.94M.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) investing activities for fiscal 2009 was -$238.23M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2012-06-30 | $42.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $71.62M 10-Q · filed 2012-07-26 | $167.11M derived: sum of 3 quarters · filed 2012-07-26 | $228.31M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | $29.45M 10-Q · filed 2012-04-26 | $124.94M derived: sum of 2 quarters · filed 2012-04-26 | $186.14M derived: sum of 3 quarters · filed 2012-04-26 | $282.21M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $95.49M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $156.69M derived: sum of 2 quarters · filed 2012-02-28 | $252.77M derived: sum of 3 quarters · filed 2012-07-26 | $277.34M 10-K · filed 2012-02-28 |
| 2011-09-30 | $61.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $157.27M derived: sum of 2 quarters · filed 2012-07-26 | $181.85M 10-Q · filed 2011-10-28 | $183.32M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $96.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $120.65M 10-Q · filed 2012-07-26 | $122.12M derived: sum of 3 quarters · filed 2012-07-26 | $122.97M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | $24.57M 10-Q · filed 2012-04-26 | $26.05M derived: sum of 2 quarters · filed 2012-04-26 | $26.89M derived: sum of 3 quarters · filed 2012-04-26 | $45.36M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $2.32M derived: sum of 2 quarters · filed 2012-02-28 | $20.79M derived: sum of 3 quarters · filed 2012-02-28 | -$167.94M 10-K · filed 2012-02-28 |
| 2010-09-30 | $848.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $19.31M derived: sum of 2 quarters · filed 2011-10-28 | -$169.41M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $18.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$170.26M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$188.73M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | -$238.23M 10-K · filed 2012-02-28 |